10 April 2017 - Only three of the 10 most deadly cancers are among those that receive­ the most funding from the National Health and Medical Research Council.

A parliamentary inquiry is examinin­g the council funding model and, according to its terms of reference, “the need to ensure the funding model enables the provision of funding research into brain cancers and other low-survival­-rate cancers”.

In a submission to the inquiry, the council has listed the cancers that received the most research funding between 2012 and last year. At the top of the list is leukaemia, which received $116,441,490 in the period, followed by breast cancer ($112,557,616), colorectal cancer ($68,357,601), childhood cancer ($60,716,931) and melanoma ($60,588,720).

Read The Australian article